Q2 2024 Holdings
Filed 2024-08-14 | 68 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immunovant Inc(IMVT) | COM | 45258J102 | $76.1M | 2,883,736 | 2.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $83.3M | 3,991,500 | 2.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $84.4M | 3,500,000 | 2.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $85.2M | 4,061,401 | 2.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $87.0M | 12,721,460 | 2.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $95.3M | 2,000,000 | 2.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $95.9M | 2,500,000 | 2.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $105.3M | 1,537,922 | 3.1% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $107.4M | 4,800,000 | 3.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $121.5M | 500,000 | 3.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $122.4M | 10,900,000 | 3.7% |
| Guardant Health Inc(GH) | COM | 40131M109 | $130.0M | 4,500,000 | 3.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $134.0M | 2,000,000 | 4.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $139.4M | 3,700,000 | 4.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $141.2M | 4,000,000 | 4.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $149.1M | 1,852,784 | 4.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $172.0M | 400,000 | 5.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $179.7M | 575,000 | 5.4% |